Elitecon International Q2 Sales Jump 538%, PAT Doubles
Elitecon International delivers spectacular Q2 FY2026 performance with 538% sales surge and doubled profits, showcasing remarkable growth trajectory in international markets.
Category : Search result: pharma profit growth
Mitsu Chem Plast Q2 Profit Jumps 66%
Mitsu Chem Plast Limited reports outstanding Q2 FY26 results with 66% net profit growth and 11% revenue increase, showcasing robust financial health and operational excellence.
Sun Pharma: US Tariff Clarity & Q2 FY26 Outlook
Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.
Indian Pharma Soars with Record US Generic Drug Profits
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma Bets on US Biopharma Funding Revival
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
Minda Corp Q2 Revenue Hits Record High, Profit Up 14%
Minda Corporation delivers stellar Q2 performance with record-breaking revenue of ₹1,288 crore and robust profit growth, signaling strong automotive sector momentum.
Bajaj Housing Finance Q2: Profit Up 18%, AUM Jumps 24%
Bajaj Housing Finance reports impressive Q2 FY2025 results with 18% net profit growth and 24% AUM surge. Discover key financial metrics and strategic insights driving this performance.
Paytm Stock Rises 4% Despite 98% Profit Drop
Paytm shares defy gravity with 4% surge despite catastrophic 98% net profit drop. Discover whether this is a buying opportunity or trap for investors.
Solara Pharma Q2 Loss: ₹10 Crore Amid Challenges
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
Sun Pharma Q2 Profit Rises 2.5% to ₹3,118 Crore
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
PSU Banks Record ₹49,456 Cr Profit in Q2
India's public sector banks achieve historic quarterly profits with 9% growth, driven by reduced bad loans and improved interest income. Discover how state-owned lenders are transforming their financial landscape.
Grasim Q2 Profit Soars 36% to ₹1,498 Crore
Grasim Industries reports stellar Q2 performance with 36% jump in net profit reaching ₹1,498 crore and robust revenue improvement of 16%. Discover the key drivers behind this impressive growth.
Navin Fluorine Shares Surge 22% in 3 Sessions
Discover why Navin Fluorine International shares skyrocketed 22% in just three trading sessions. Expert analysis reveals the key drivers behind this chemical sector powerhouse's impressive rally and what investors should watch next.
Q2 Results Today: Sun Pharma, Grasim, Britannia Earnings
Market eyes Wednesday's Q2 earnings bonanza as pharma giant Sun Pharma, Grasim Industries, and FMCG major Britannia declare results. Get complete analysis and investor expectations.
Paytm posts ₹211 cr profit, revenue jumps 24%
Paytm continues its impressive financial turnaround with consecutive profitable quarters, driven by strong growth in financial services and expanding user base.
Mahindra Q4 Profit Soars 32% on Strong Tractor, SUV Sales
Mahindra & Mahindra reports impressive 32% profit surge in Q4 FY24, fueled by robust tractor and SUV sales. Discover how GST cuts and electric vehicle expansion are shaping India's auto sector.
3 Hot Stocks: Grasim, Aurobindo Pharma, City Union Bank
Religare Broking's Ajit Mishra reveals 3 promising stocks for short-term gains. Discover technical analysis and price targets for Grasim, Aurobindo Pharma, and City Union Bank in this exclusive market insight.
Airtel Q2 Profit Jumps 89%, Adds 2.6M Premium Users
Bharti Airtel delivers stellar Q2 results with massive profit surge and robust subscriber growth, outpacing Reliance Jio in key metrics. Discover how their 5G strategy is paying off.
GHV Infra Q2: Revenue up 128%, Profit jumps 138%
GHV Infra Projects delivers explosive Q2 performance with revenue skyrocketing 128% and profits surging 138%, signaling strong growth momentum in India's infrastructure sector.
Airtel Q2 Profit Surges 89%, ARPU Hits ₹203
Bharti Airtel reports stellar Q2 results with 89% YoY profit surge to ₹6,792 crore. ARPU climbs to ₹203, revenue grows 7.3% as 5G expansion drives performance.
Digikore Studios PAT Jumps 117% in H1 FY26
Mumbai-based Digikore Studios reports staggering 117% YoY profit growth in H1 FY26, with revenue climbing 77% as demand for VFX and animation services skyrockets globally.
Sigma Solve Q2 Profit Jumps 54% to ₹1.93 Crore
Sigma Solve Limited reports impressive Q2 FY25 results with 54% YoY profit surge, revenue growth of 26.65%, and expanding EBITDA margins. The tech solutions provider demonstrates strong financial performance.
Hot Stocks: Oil India, Aurobindo Pharma, Latent View Analysis
Get expert stock market insights from Jigar Patel of Anand Rathi as he reveals why Oil India, Aurobindo Pharma, and Latent View Analytics present compelling short-term opportunities for Indian investors.
Health Biotech Expands Global Presence at CPhI Frankfurt
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Equitas SFB Q2: Profit Up 35%, NII Dips 3%
Equitas Small Finance Bank reports strong Q2 performance with 35% profit growth, though NII sees decline. Get complete analysis of provisions, asset quality, and business highlights.
Niner Pharma Expands R&D with 125 New Peptide Molecules
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
Small-Cap Multibagger Jumps 7% After 94% Profit Surge
Discover how this small-cap multibagger stock delivered explosive Q2 FY2025 results with 94% profit surge and 39% revenue growth, triggering massive investor interest.
ACC Q2 Profit Soars to ₹1,119 Crore, Revenue Up 30%
ACC Limited reports blockbuster Q2 FY26 results with net profit skyrocketing to ₹1,119 crore and revenue surging 30% year-on-year. The Adani-owned cement major demonstrates robust operational performance amid strong market demand.
Apple iPhone Drives Record Sales and Profit Surge
Apple's iPhone drives unprecedented revenue growth with record-breaking sales, defying global smartphone market trends and setting new benchmarks for profitability.
Page 2 of 4